Barriers for conducting clinical trials in developing countries- a systematic review
Abstract Background Clinical trials for identification of efficient and effective new diagnostic and treatment modalities are needed to address disproportionately high burden of communicable (e.g., HIV/AIDS, tuberculosis, and malaria) and non-communicable diseases (e.g., diabetes) in developing coun...
Main Authors: | Chalachew Alemayehu, Geoffrey Mitchell, Jane Nikles |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | International Journal for Equity in Health |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12939-018-0748-6 |
Similar Items
-
N-of-1 trials in the clinical care of patients in developing countries: a systematic review
by: Chalachew Alemayehu, et al.
Published: (2018-04-01) -
Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
by: Edgardo Rodríguez-Torres, et al.
Published: (2021-09-01) -
Barriers to the conduct of randomised clinical trials within all disease areas
by: Snezana Djurisic, et al.
Published: (2017-08-01) -
Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study
by: Kanarek Norma F, et al.
Published: (2012-12-01) -
Specific barriers to the conduct of randomised clinical trials on medical devices
by: Edmund A. M. Neugebauer, et al.
Published: (2017-09-01)